BMP2 and breast carcinoma: A kinase inactive type II TGF-β receptor (dnTbetaRII) eliminated the anti-proliferative effect of BMP-2 in breast cancer cells by preventing the phosphorylation of Smad-1 (Dumont & Arteaga 2003).